Audentes Therapeutics Inc (NASDAQ:BOLD) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark Alan Goldberg Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past); Synageva BioPharma Corp (EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past) | Director · Dec 11, 2017 – Jan 15, 2020 · Past |
| Edward R. Conner Other companies: Jade Biosciences, Inc. (Chief Medical Officer · Since at least Apr 23, 2026); Ardelyx, Inc. (Chief Medical Officer · Since at least Aug 1, 2025); Third Harmonic Bio Inc. (Chief Medical Officer · Sep 14, 2022 – Jan 15, 2025 · Past); Enliven Therapeutics, Inc. (Director · Apr 22, 2020 – Jun 2, 2022 · Past); Sangamo Therapeutics, Inc. (Sr. VP & Chief Medical Officer · Nov 30, 2016 – Jan 24, 2019 · Past) | SVP, Chief Medical Officer · Jul 15, 2019 – Jan 15, 2020 · Past |
| Louis G Lange Other companies: NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Epiphany Technology Acquisition Corp (Director · Sep 16, 2022 – Sep 16, 2022 · Past); BioPlus Acquisition Corp (Director · Dec 2, 2021 – Dec 2, 2021 · Past); Esperion Therapeutics, Inc. (Director · Jun 25, 2013 – Jul 1, 2013 · Past); Maxygen Inc (Director · May 27, 2010 – Jun 6, 2012 · Past) | Director · Jul 19, 2016 – Jan 15, 2020 · Past |
| Matthew R Patterson Other companies: Vor Biopharma Inc. (Director · Feb 4, 2021 – May 22, 2025 · Past); 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 14, 2023 · Past) | Chief Executive Officer, Director · Jul 19, 2016 – Jan 15, 2020 · Past |
| Mark Meltz Other companies: Lyell Immunopharma, Inc. (General Counsel and Corporate Secretary · Since at least Jun 9, 2025); Kinnate Biopharma Inc (COO GENERAL COUNSEL SECRETARY · Dec 2, 2020 – Apr 3, 2024 · Past) | SVP, General Counsel · Mar 28, 2019 – Jan 15, 2020 · Past |
| Thomas J. Schuetz Other companies: Compass Therapeutics, Inc. (Chief Executive Officer, Compass Therapeutics · Since at least Jun 17, 2020); Relypsa Inc (Director · Nov 14, 2013 – Sep 1, 2016 · Past) | Director · Jul 19, 2016 – Jan 15, 2020 · Past |
| John T Gray | SVP, Chief Scientific Officer · Jul 19, 2016 – Sep 28, 2018 · Past |
| Mary Newman | SVP, Regulatory Affairs · Jul 19, 2016 – Nov 15, 2018 · Past |